Background Intensive chemotherapy with severe neutropenia is associated with invasive
fungal infections (IFIs) leading to high mortality rates. During leukaemia induction …

This is a retrospective, single-center study of adult patients with newly diagnosed acute
myelogenous leukemia (AML), who received intensive induction timed sequential …

Few reports analyze the incidence and clinical outcome of invasive fungal disease (IFD) in
patients with newly diagnosed acute myeloid leukemia (AML) undergoing intensive …

Although primary antifungal prophylaxis (PAP) is routinely administered in patients with
acute myeloid leukemia (AML) during remission-induction and consolidation chemotherapy …

This stud y examined the epidemiology, risk factors, management, and outcome of invasive
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …

Objectives We sought to determine the occurrence, risk factors, effect of antifungal
prophylaxis, and outcomes of invasive fungal infections (IFIs) in patients with acute myeloid …

Objectives Antifungal prophylaxis is recommended for haematological patients at high risk of
invasive fungal infections (IFIs). Incidence, optimal therapeutic management and outcome of …

The incidence of invasive fungal infection (IFI) in patients with acute myeloid leukemia (AML)
has decreased with the introduction of antimold prophylaxis. Although acute lymphoblastic …

Invasive fungal infections (IFIs) is an important complication for acute myeloid leukemia
(AML) patients receiving induction chemotherapy. However, the epidemiological information …

Background Invasive fungal infection (IFI) causes high morbidity and mortality during acute
myeloid leukemia (AML) treatment. Interventions to prevent fungal infection, including air …